MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03244nam a2200301 u 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
4904 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
GrATPDL |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240201094045.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
890105s1989 gw a b 101 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
3540505342 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
GrATPDL |
| Modifying agency |
ΕΘΝΙΚΗ ΣΧΟΛΗ ΔΗΜΟΣΙΑΣ ΥΓΕΙΑΣ-ΚΕΝΤΡΙΚΗ ΒΙΒΛΙΟΘΗΚΗ |
| Transcribing agency |
ΠΑΝΕΠΙΣΤΗΜΙΟΥΠΟΛΗ ΑΘΗΝΩΝ |
| 041 0# - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.19 |
| 245 04 - TITLE STATEMENT |
|---|
| Title |
The perception and management of drug safety risks / |
| Statement of responsibility, etc. |
edited by Bruno Horisberger, Rolf Dinkel. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Berlin, Heidelberg ; |
| -- |
New York : |
| Name of publisher, distributor, etc. |
Springer Berlin Heidelberg, |
| Date of publication, distribution, etc. |
1989. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxiii, 210 σ. : |
| Other physical details |
εικ., διαγρ., πιν. ; |
| Dimensions |
25 εκ. |
| 490 0# - SERIES STATEMENT |
|---|
| Series statement |
Health Systems Research ; |
| Volume/sequential designation |
1431-4002 |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Περιέχει παράρτημα με τα Βιογραφικά των συγγραφέων, γλωσσαριο και πίνακες. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Βιβλιογραφία : σ.191-201. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Opening Address -- I: Society and the Benefit/Risk Relationship -- 1. Acceptable Risk in Society -- 2. A Broad Framework for Confronting Health Risks -- 3. Communicating the Risks and Benefits of Technology: The Case of Pharmaceuticals -- 4. Overview of the Drug Safety Issue and Ciba-Geigy’s Response: RAD-AR -- 5. Summary of Part I: Presentations and Discussions -- II: Benefit/Risk Analysis and Appraisal -- 6. Limitations of Available Sources of Data on Prescription Drug Safety -- 7. Strategies, Designs, Criteria, Tactics and Statistics to be Considered when Evaluating Scientific Evidence -- 8. Statistics in Drug Risk Research: The Background of Pharmacoepidemiology -- 9. Industry-Sponsored Risk Institutes -- 10. The Feldene Experience: A Case Study -- 11. Risk Perception of Prescription Drugs: Report on a Survey in Sweden -- 12. Risk Perception of Prescription Drugs: Report on Surveys in Japan -- 13. Scientific and Political Components of Regulatory Decision Making: General Considerations -- 14. Scientific and Political Components of Regulatory Decision Making: The United States Experience -- 15. Summary of Part II: Presentations and Discussions -- III: Current Challenges -- 16. Professional Drug Information: A Consumer Perspective -- 17. Going Patient, Going Public -- 18. Reporting Adverse Drug Reactions: The Media Approach -- 19. What Can Be Learned from Drug Safety Issues? -- 20. Summary of Part III: Presentations and Discussions -- IV: Responding to the Issues -- 21. Editor’s Note -- 22. Pharmacoepidemiology -- 23. Risk Perception Analysis -- 24. Communicating the Benefit/Risk Relationship -- 25. Risk Appraisal on an International Scale -- V: Outlook -- 26. The Wolfsberg Questions -- VI: Annex -- 27. Curriculum Vitae of Authors -- 28. Bibliography -- 29. Subject Index -- 30. A Handbook of International Data Sources for Drug Benefit/Risk Assessment. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Health risk assessment. |
| 9 (RLIN) |
4495 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Εκτίμηση κινδύνου για την υγεία. |
| 9 (RLIN) |
4496 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Φαρμακολογία. |
| 9 (RLIN) |
3270 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology. |
| 9 (RLIN) |
3269 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Horisberger, Bruno. |
| Relator term |
Επιμελητής |
| 9 (RLIN) |
5825 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Dinkel, Rolf. |
| Relator term |
Επιμελητής |
| 9 (RLIN) |
5826 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |
| Classification part |
615.19 PER |